勘误：食欲增加在首发精神分裂症患者奥氮平所致体重增加中起关键作用。
Corrigendum: Increased Appetite Plays a Key Role in Olanzapine-Induced Weight Gain in First-Episode Schizophrenia Patients.
作者信息
Huang Jing, Hei Gang-Rui, Yang Ye, Liu Chen-Chen, Xiao Jing-Mei, Long Yu-Jun, Peng Xing-Jie, Yang Yi, Zhao Jing-Ping, Wu Ren-Rong
机构信息
Mental Health Institute of the Second Xiangya Hospital, Central South University, Changsha, China.
China National Clinical Research Center on Mental Disorders, Changsha, China.
出版信息
Front Pharmacol. 2020 Jun 10;11:878. doi: 10.3389/fphar.2020.00878. eCollection 2020.
Abstract
[This corrects the article DOI: 10.3389/fphar.2020.00739.].
摘要
[本文更正了文章DOI：10.3389/fphar.2020.00739。]
相似文献
1
Corrigendum: Increased Appetite Plays a Key Role in Olanzapine-Induced Weight Gain in First-Episode Schizophrenia Patients.勘误：食欲增加在首发精神分裂症患者奥氮平所致体重增加中起关键作用。
Front Pharmacol. 2020 Jun 10;11:878. doi: 10.3389/fphar.2020.00878. eCollection 2020.
2
Increased Appetite Plays a Key Role in Olanzapine-Induced Weight Gain in First-Episode Schizophrenia Patients.食欲增加在首发精神分裂症患者奥氮平所致体重增加中起关键作用。
Front Pharmacol. 2020 May 22;11:739. doi: 10.3389/fphar.2020.00739. eCollection 2020.
3
Factors influencing acute weight change in patients with schizophrenia treated with olanzapine, haloperidol, or risperidone.奥氮平、氟哌啶醇或利培酮治疗的精神分裂症患者急性体重变化的影响因素。
J Clin Psychiatry. 2001 Apr;62(4):231-8. doi: 10.4088/jcp.v62n0404.
4
Predictors of antipsychotic-induced weight gain in first-episode psychosis: conclusions from a randomized, double-blind, controlled prospective study of olanzapine, risperidone, and haloperidol.首发精神病患者抗精神病药物所致体重增加的预测因素：一项关于奥氮平、利培酮和氟哌啶醇的随机、双盲、对照前瞻性研究的结论
J Clin Psychopharmacol. 2008 Feb;28(1):27-31. doi: 10.1097/jcp.0b013e3181602fe6.
5
Olanzapine and risperidone effects on appetite and ghrelin in chronic schizophrenic patients.奥氮平和利培酮对慢性精神分裂症患者食欲和胃饥饿素的影响。
Psychiatry Res. 2012 Oct 30;199(3):159-63. doi: 10.1016/j.psychres.2012.03.011. Epub 2012 Apr 3.
6
Attenuation of olanzapine-induced weight gain with reboxetine in patients with schizophrenia: a double-blind, placebo-controlled study.瑞波西汀减轻精神分裂症患者奥氮平所致体重增加的双盲、安慰剂对照研究。
Am J Psychiatry. 2003 Feb;160(2):297-302. doi: 10.1176/appi.ajp.160.2.297.
7
Olanzapine increases plasma ghrelin level in patients with schizophrenia.奥氮平可提高精神分裂症患者的血浆胃饥饿素水平。
Psychoneuroendocrinology. 2005 Jan;30(1):106-10. doi: 10.1016/j.psyneuen.2004.05.008.
8
The effect of betahistine, a histamine H1 receptor agonist/H3 antagonist, on olanzapine-induced weight gain in first-episode schizophrenia patients.组胺H1受体激动剂/ H3拮抗剂倍他司汀对首发精神分裂症患者奥氮平所致体重增加的影响。
Int Clin Psychopharmacol. 2005 Mar;20(2):101-3. doi: 10.1097/00004850-200503000-00007.
9
Olanzapine for schizophrenia.奥氮平用于治疗精神分裂症。
Cochrane Database Syst Rev. 2005 Apr 18;2005(2):CD001359. doi: 10.1002/14651858.CD001359.pub2.
10
The effect of famotidine addition on olanzapine-induced weight gain in first-episode schizophrenia patients: a double-blind placebo-controlled pilot study.法莫替丁添加对首发精神分裂症患者奥氮平所致体重增加的影响：一项双盲安慰剂对照的前瞻性研究。
Eur Neuropsychopharmacol. 2004 Aug;14(4):332-6. doi: 10.1016/j.euroneuro.2003.10.004.
Zotero 插件